Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Cory

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Advances in Enzyme Regulation|January 1, 1985
Drug action on ribonucleotide reductaseJ G Cory, G L Carter
International Journal of Oncology|July 31, 1999
Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agentsT R Crenshaw, J G Cory
Oncology Research|May 1, 1999
Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cellsA W He, J G Cory
Enzymologia|June 30, 1970
Ribonucleotide reductase activity during the growth of Ehrlich ascites tumorJ G Cory, B D Boss
Biochemical Pharmacology|September 1, 1982
Evidence that 5'-deoxy-5-fluorouridine may not be activated by the same mechanism as 5-fluorouracilJ G Cory, G L Carter
Cancer Research|September 1, 1975
Comparison of the cytidine 5'-diphosphate and adenosine 5'-diphosphate reductase activities of mammalian ribonucleotide reductaseJ G Cory, M M Mansell
Cancer Research|November 1, 1979
Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapyJ G Cory, A E Fleischer
Cancer Research|June 1, 1972
Ribonucleotide reductase and DNA synthesis in Ehrlich ascites tumor cellsJ G Cory, T W Whitford
Cancer Research|February 15, 1988
Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitorsJ G Cory, G L Carter
Biochemical Pharmacology|March 15, 1979
Dialdehyde derivative of 5'-deoxyinosine as a more potent analog of the dialdehyde derivative of inosine (NSC 118994)J G Cory, S H Parker
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Advances in Enzyme Regulation|January 1, 1985
Drug action on ribonucleotide reductaseJ G Cory, G L Carter
International Journal of Oncology|July 31, 1999
Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agentsT R Crenshaw, J G Cory
Oncology Research|May 1, 1999
Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cellsA W He, J G Cory
Enzymologia|June 30, 1970
Ribonucleotide reductase activity during the growth of Ehrlich ascites tumorJ G Cory, B D Boss
Biochemical Pharmacology|September 1, 1982
Evidence that 5'-deoxy-5-fluorouridine may not be activated by the same mechanism as 5-fluorouracilJ G Cory, G L Carter
Cancer Research|September 1, 1975
Comparison of the cytidine 5'-diphosphate and adenosine 5'-diphosphate reductase activities of mammalian ribonucleotide reductaseJ G Cory, M M Mansell
Cancer Research|November 1, 1979
Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapyJ G Cory, A E Fleischer
Cancer Research|June 1, 1972
Ribonucleotide reductase and DNA synthesis in Ehrlich ascites tumor cellsJ G Cory, T W Whitford
Cancer Research|February 15, 1988
Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitorsJ G Cory, G L Carter
Biochemical Pharmacology|March 15, 1979
Dialdehyde derivative of 5'-deoxyinosine as a more potent analog of the dialdehyde derivative of inosine (NSC 118994)J G Cory, S H Parker
Pageof 12